Blocking Fat Production Enzyme Protects Hearts From Dangerous Enlargement
New research shows inhibiting fatty acid synthase prevents cardiac hypertrophy and restores heart function in multiple models.
Summary
Scientists discovered that blocking fatty acid synthase (FAS), an enzyme that makes fat in cells, protects against cardiac hypertrophy - dangerous heart enlargement that leads to heart failure. Using cell cultures and two rat models, researchers found that inhibiting FAS prevented heart muscle thickening, reduced harmful protein buildup, and restored normal energy production in heart cells. This suggests targeting fat production pathways could offer a new treatment approach for preventing heart failure.
Detailed Summary
Heart enlargement (cardiac hypertrophy) is a dangerous condition where heart muscle thickens abnormally, often progressing to heart failure. While scientists know disturbed metabolism plays a key role, the specific mechanisms remain unclear.
Researchers investigated fatty acid synthase (FAS), an enzyme that produces fat molecules in cells. They used human heart cells exposed to phenylephrine to mimic hypertrophy, plus two rat models that create heart enlargement through different mechanisms.
The results were striking: FAS activity increased dramatically in all hypertrophy models. When researchers blocked FAS using genetic techniques in cells or the drug C75 in rats, they prevented heart enlargement and restored normal function. Specifically, FAS inhibition reduced harmful protein synthesis, decreased cell death, lowered oxidative stress, and restored proper energy production in mitochondria.
In rats, blocking FAS prevented the structural heart changes seen in hypertrophy models. It also increased cellular energy (ATP) levels and restored normal mitochondrial function, suggesting the heart's power plants were working properly again.
These findings suggest that targeting fat production pathways could offer a novel therapeutic approach for preventing heart failure. Since cardiac hypertrophy often precedes heart failure - a leading cause of death worldwide - interventions that prevent this progression could have major clinical impact. However, this research used animal models and cell cultures, so human trials would be needed to confirm these protective effects and determine optimal dosing strategies.
Key Findings
- Fatty acid synthase activity increases significantly during cardiac hypertrophy development
- Blocking FAS prevents heart muscle thickening and structural remodeling in multiple models
- FAS inhibition restores normal mitochondrial function and cellular energy production
- Treatment reduces harmful protein synthesis and oxidative stress in heart cells
- C75 drug effectively prevented cardiac hypertrophy when given weekly for 8 weeks
Methodology
Study used human heart cell cultures treated with phenylephrine plus two established rat models of cardiac hypertrophy (2K1C and TAC). FAS was inhibited using genetic silencing in cells and C75 drug treatment in animals.
Study Limitations
Summary based on abstract only. Animal and cell culture models may not fully translate to humans. Long-term safety and optimal dosing of FAS inhibitors in humans remains unknown.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.